Target intelligence / Profile preview

Splice donor sequence and splice acceptor sequence

Molecular classification
Other
01

Overview

Splice donor and acceptor sequences are short, highly conserved nucleotide motifs at the exon-intron boundaries in eukaryotic genes. The splice donor site is located at the 5' end of the intron and almost always features the dinucleotide "GU" (and less commonly GC or AT), while the splice acceptor site is at the 3' end and is usually "AG". The correct identification and processing of these sites by the spliceosome ensures removal of introns and ligation of exons to create mature mRNA. Mutations in these consensus sequences (splice site mutations) can cause mis-splicing, leading to retention of introns or skipping of exons, often resulting in nonfunctional or deleterious proteins, and are a significant cause of genetic diseases. These sites are not themselves drug targets, but rather regulatory genomic elements critical for normal gene expression and are a focus for genetic diagnosis and gene therapy development.

Other names
canonical splice sites5' splice site (donor site)3' splice site (acceptor site)GT-AG splice siteGC-AG siteAT-AC site
02

Biological functions

mRNA splicingExon definitionRemoval of intronsmRNA maturation
03

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInherited genetic disorders (e.g., cystic fibrosis, Duchenne muscular dystrophy, Peutz-Jeghers syndrome)

Beyond the preview

Go deeper on Splice donor sequence and splice acceptor sequence.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Splice donor sequence and splice acceptor sequence.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call